Area of Research: Targeted Therapy
2022 Grant Recipients
- Pamela Rojas de Santiago, PhD, University of Pennsylvania Mentored Investigator GrantInvestigating the Therapeutic Potential of CRABP2 in HGSOC
2021 Grant Recipients
- Anne M. van Harten, PhD, Thomas Jefferson University Mentored Investigator GrantTargeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
- Wei Zhou, PhD, The Wistar Institute Mentored Investigator GrantTargeting the mevalonate pathway in ARID1A-mutated ovarian cancer
2020 Grant Recipients
- Jianhuang Lin, PhD, The Wistar Institute Mentored Investigator GrantTargeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
- Boris Winterhoff, MD, University of Minnesota Twin Cities Early Career Investigator GrantPrecision Medicine in Ovarian Cancer: Using Single Cell Analysis
2018 Grant Recipients
- Goldie Lui, PhD, Fred Hutchinson Cancer Research Center Mentored Investigator GrantIdentifying Novel Targeted Therapies for MYC-driven Ovarian Cancer
- David Sabatini, MD, PhD, Whitehead Institute for Biomedical Research Collaborative Research Development GrantA Personalized Approach to Identify and Target Ovarian Cancer Liabilities
2017 Grant Recipients
- Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine Collaborative Research Development GrantDevelopment of Targeted Therapies for Recurrent Ovarian Cancer
2015 Grant Recipients
- Sarah Walker, PhD, Dana Farber Cancer Institute Early Career Investigator GrantTargeting Transcription Factor Networks for Ovarian Cancer Therapy
- Kris Wood, PhD, Duke University Early Career Investigator GrantDefining New Combination Therapies for High-grade Serous Ovarian Cancer